TN2020000219A1 - Composes peptidiques multiepitopiques et vaccins contre la leishmaniose - Google Patents

Composes peptidiques multiepitopiques et vaccins contre la leishmaniose

Info

Publication number
TN2020000219A1
TN2020000219A1 TNP/2020/000219A TN2020000219A TN2020000219A1 TN 2020000219 A1 TN2020000219 A1 TN 2020000219A1 TN 2020000219 A TN2020000219 A TN 2020000219A TN 2020000219 A1 TN2020000219 A1 TN 2020000219A1
Authority
TN
Tunisia
Prior art keywords
peptide compounds
multiepitopic peptide
leishmaniasis
vaccines
leishmaniasis vaccines
Prior art date
Application number
TNP/2020/000219A
Other languages
English (en)
Inventor
Gonçalves Rachel Bras
Amel Garnaoui
Jean-Loup Lemesre
Elodie Petitdidier-Lesin
Original Assignee
Institut De Rech Pour Le Developpement
Pasteur Institut Tunis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut De Rech Pour Le Developpement, Pasteur Institut Tunis filed Critical Institut De Rech Pour Le Developpement
Publication of TN2020000219A1 publication Critical patent/TN2020000219A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/008—Leishmania antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
TNP/2020/000219A 2018-05-30 2019-05-29 Composes peptidiques multiepitopiques et vaccins contre la leishmaniose TN2020000219A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1800533A FR3081870B1 (fr) 2018-05-30 2018-05-30 Epitopes, composes peptidiques mono-ou multiepitopiques et vaccins contre la leishmanie
PCT/EP2019/064088 WO2019243018A1 (fr) 2018-05-30 2019-05-29 Composes peptidiques multiepitopiques et vaccins contre la leishmaniose

Publications (1)

Publication Number Publication Date
TN2020000219A1 true TN2020000219A1 (fr) 2022-07-01

Family

ID=65494127

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP/2020/000219A TN2020000219A1 (fr) 2018-05-30 2019-05-29 Composes peptidiques multiepitopiques et vaccins contre la leishmaniose

Country Status (6)

Country Link
US (1) US11559575B2 (fr)
EP (1) EP3801608A1 (fr)
BR (1) BR112020024211A2 (fr)
FR (1) FR3081870B1 (fr)
TN (1) TN2020000219A1 (fr)
WO (1) WO2019243018A1 (fr)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2705358B1 (fr) 1993-05-13 1995-08-04 Orstom Procédé de culture in vitro de différents stades de parasites tissulaires, stades parasitaires obtenus et applications biologiques.
FR3000402A1 (fr) 2012-12-28 2014-07-04 Vibrac Composes peptidiques mono-ou multi-epitopiques destines a la prevention et au traitement des leishmanioses
WO2014160987A2 (fr) * 2013-03-28 2014-10-02 Infectious Disease Research Institute Vaccins comprenant des polypeptides de leishmania pour le traitement et le diagnostic de la leishmaniose
US9804158B2 (en) 2013-07-02 2017-10-31 Institut De Recherche Pour Le Développement Peptides and methods for the detection of Leishmaniasis
FR3014103B1 (fr) 2013-11-29 2019-08-16 Institut De Recherche Pour Le Developpement (Ird) Composition vaccinale pour la prevention et/ou le traitement de leishmanioses, peptides immunogenes et procede d'obtention

Also Published As

Publication number Publication date
EP3801608A1 (fr) 2021-04-14
WO2019243018A1 (fr) 2019-12-26
FR3081870A1 (fr) 2019-12-06
BR112020024211A2 (pt) 2021-02-17
US20210213114A1 (en) 2021-07-15
FR3081870B1 (fr) 2024-04-19
US11559575B2 (en) 2023-01-24

Similar Documents

Publication Publication Date Title
CA194407S (en) Teether
MA50813A (fr) Vaccins contre le virus d'epstein-barr
MA46584A (fr) Vaccin contre le cytomégalovirus humain
RS61346B1 (sr) Farmaceutske kompozicije koje obuhvataju meloksikam i rizatriptan
GB2569961B (en) Pharmaceutical
MA47677A (fr) Vaccins peptidiques
MA46316A (fr) Vaccin contre le cytomégalovirus humain
GB201800074D0 (en) Pharmaceutical
GB2572125B (en) Pharmaceutical
GB201807942D0 (en) Pharmaceutical formulation
DK3709978T3 (da) Farmaceutisk oral formulering omfattende bakterier
ES2972844T3 (es) Preparación farmacéutica
PT3568022T (pt) Proteínas inseticidas
MA52011A (fr) Vaccins peptidiques contre l'interleukine-31
ZA202006570B (en) Pharmaceutical formulations
MA44067A (fr) Anticorps dirigés contre la quétiapine et utilisation associée
ZA202102871B (en) Pharmaceutical formulation
SG11202010124SA (en) Stable pharmaceutical formulation
IL281224A (en) Peptide compounds
IL278927A (en) pharmaceutical preparation
EP3299384A4 (fr) Protéine vp4 tronquée de rotavirus et son application
DK3886820T3 (da) Kapselformuleringer
TN2020000219A1 (fr) Composes peptidiques multiepitopiques et vaccins contre la leishmaniose
IL280450A (en) A peptide derived from cdca1 and a preparation containing it
ZA202006346B (en) Pharmaceutical preparation